BioMarin Appoints Former CEO of Celgene Corporation, Mark Alles, to Board of Directors

SAN RAFAEL, Calif.: SAN RAFAEL, Calif., Dec. 15, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a global leader in providing therapies for rare genetic diseases, today announced the appointment of former CEO of Celgene Corporation, Mark Alles, to its Board of Directors effective January 1, 2022. "We are thrilled to...

Click to view original post